The clinical trial supplies market has seen considerable growth due to a variety of factors.
•In the past few years, there has been substantial growth in the clinical trial supplies market size. The market is projected to expand from $2.68 billion in 2024 to $2.88 billion in 2025, with a compound annual growth rate (CAGR) of 7.8%.
The significant growth witnessed in the historical period can be ascribed to the escalating prevalence of chronic diseases, stringent regulatory protocols, increased demand for clinical trials for the creation of new treatments, and escalating intricacy of clinical trials.
The clinical trial supplies market is expected to maintain its strong growth trajectory in upcoming years.
• The market for clinical trial supplies is predicted to see robust expansion in the upcoming years, with its value expected to soar to $4.03 billion by 2029, growing at a Compound Annual Growth Rate (CAGR) of 8.7%.
This predicted growth in the forecast period can be linked to factors such as the globalization of clinical trials, uptick in cell and gene therapy trials, amplified attention on patient-centric trials, increasing number of biologics and biosimilar drug trials, and the emergence of virtual and decentralized trials. Key emerging trends for this forecast period encompass the incorporation of Artificial Intelligence (AI) and predictive analytics, advancements in 3D printing, escalated focus on sustainability and ecological compatibility in clinical trial supplies management, increased R&D investment by biopharmaceutical and pharmaceutical firms, and progress in blockchain technology.
The clinical trial supplies market is projected to expand due to the rising number of registered clinical trials. Clinical trials, being research studies conducted on human subjects to assess the safety and utility of novel medical treatments, interventions, or diagnostic protocols, necessitate supplies such as pharmaceuticals, medical devices, and other vital materials. These supplies underpin the research process, facilitate precise data collection, and ensure patient safety during trials. For example, data from ClinicalTrials.gov, an affiliate of the National Institutes of Health (NIH), a government agency in the US devoted to conducting and supporting medical research, indicates that approximately 437,533 clinical trials were registered in 2023, up from 399,499 registered studies in 2022 across all 50 states in the US and 221 countries worldwide. Consequently, the escalating number of registered clinical trials is propelling the growth of the clinical trial supplies market.
The clinical trial supplies market covered in this report is segmented –
1) By Services: Logistics And Distribution, Storage And Retention, Supply Chain Management, Packaging, Labeling, And Blinding, Manufacturing, Comparator Sourcing
2) By Clinical Phases: Phase I, Phase II, Phase III, Phase IV
3) By Therapeutic Use: Oncology, Central Nervous System (CNS), Cardiovascular, Infectious Disease, Metabolic Disorders, Other Therapeutic Uses
4) By End User: Pharmaceutical And Biotech companies, Contract Research Organization (CRO), Medical Device Companies
Subsegments:
1) By Logistics And Distribution: Transportation, Inventory Management, Temperature-Controlled Shipping, Customs Clearance
2) By Storage And Retention: Short-term Storage, Long-term Storage, Controlled Environment Storage
3) By Supply Chain Management: Planning And Forecasting, Supplier Management, Risk Management, Compliance Management
4) By Packaging, Labeling, And Blinding: Primary Packaging, Secondary Packaging, Label Design And Printing, Blinding Techniques
5) By Manufacturing: Active Pharmaceutical Ingredient (API) Production, Formulation Development, Batch Production
6) By Comparator Sourcing: Sourcing Of Reference Products, Quality Control And Assurance, Regulatory Compliance For Comparators
The adoption of advancements in real-world evidence platforms is an emerging trend that is gaining traction in the clinical trial supplies market. Many of the leading companies in this market are embracing groundbreaking technologies to revolutionize healthcare decision-making, medicine creation, and patient care by employing real-world information to produce evidence-based analysis and maintain their position in the sector. A key example of this is Komodo Health, a healthcare technology firm based in the United States, known for its services in patient recruitment, site selection, and real-time data monitoring for clinical trials. In April 2023, the company introduced MapEnhance, an interconnected network of specialized data partners built into a real-world evidence (RWE) tech platform. MapEnhance equips clients with an extensive and intricate real-world view of clinical occurrences and patient groups, facilitating unparalleled intelligence. The features of MapEnhance range from precision molecular diagnostics for multiple therapy areas and large-scale standard laboratory diagnostics for early disease detection to electronic clinical records documenting clinical interactions. Additionally, it provides chargemasters for inpatient and outpatient facilities, which give detailed information on costs and utilization across different hospital settings.
Major companies operating in the clinical trial supplies market include:
• Thermo Fisher Scientific Inc.
• IQVIA
• Eurofins Scientific SE
• Parexel International Corporation
• ICON PLC
• Catalent Inc.
• Intertek Group PLC
• Recipharm AB
• World Courier
• Almac Group Ltd.
• Piramal Pharma Solutions
• Clinigen Group PLC
• Movianto GmbH
• Marken Limited
• PCI Pharma Services
• Rubicon Research Private Limited
• Bionical Ltd.
• Durbin PLC
• SIRO Clinpharm Pvt. Ltd.
• Biocair International Ltd.
• Ancillare LP.
• Myonex
• Klifo A/S
• Alium Medical Limited
• ADAllen Pharma
• Sharp Services LLC
North America was the largest region in the clinical trial supplies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical trial supplies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.